Q32 Bio (QTTB) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $7.52, -3.22% vs the prior close of $7.77.
- Volume 677.99K shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
QTTB slides 3.2% to $7.52, a 3-month low, 4 down days in a row. Closed at $7.52, -3.22% vs the prior close of $7.77. Day range $7.28–$7.82, opened at $7.82.
QTTB daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — QTTB slides 3.2% to $7.52, a 3-month low, 4 down days in a row
- Closed at $7.52, -3.22% vs the prior close of $7.77. Day range $7.28–$7.82, opened at $7.82.
- Volume was 677.99K shares, 0.9x its 50-day average of 774.33K.
- Price is -36.4% vs its 50-day average ($11.83) and -16.2% vs its 200-day average ($8.98).
- 52-week range $1.90–$23.57; today's close sits at 26% of that range, 68.1% below the 52-week high.
- That makes 4 straight losses.
Oct 15, 2026 — QTTB dips 3.0% to $7.77, a 3-month low, 3 down days in a row
- Closed at $7.77, -3.00% vs the prior close of $8.01. Day range $7.72–$8.29, opened at $8.01.
- Volume was 625.30K shares, 0.8x its 50-day average of 774.86K.
- Price is -35.3% vs its 50-day average ($12.00) and -13.2% vs its 200-day average ($8.95).
- 52-week range $1.90–$23.57; today's close sits at 27% of that range, 67.0% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — QTTB dips 0.6% to $8.01
- Closed at $8.01, -0.62% vs the prior close of $8.06. Day range $7.72–$8.30, opened at $7.93.
- Volume was 889.30K shares, 1.2x its 50-day average of 771.63K.
- Price is -34.2% vs its 50-day average ($12.17) and -10.3% vs its 200-day average ($8.93).
- 52-week range $1.90–$23.57; today's close sits at 28% of that range, 66.0% below the 52-week high.
Oct 13, 2026 — QTTB slides 7.8% to $8.06
- Closed at $8.06, -7.78% vs the prior close of $8.74. Day range $7.89–$8.69, opened at $8.69.
- Volume was 719.80K shares, 0.9x its 50-day average of 763.81K.
- Price is -34.7% vs its 50-day average ($12.34) and -9.5% vs its 200-day average ($8.91).
- 52-week range $1.90–$23.57; today's close sits at 28% of that range, 65.8% below the 52-week high.
Oct 12, 2026 — QTTB jumps 4.8% to $8.74, 3 up days in a row
- Closed at $8.74, +4.80% vs the prior close of $8.34. Day range $8.44–$9.15, opened at $8.64.
- Volume was 682.30K shares, 0.9x its 50-day average of 757.90K.
- Price is -30.0% vs its 50-day average ($12.48) and -1.6% vs its 200-day average ($8.88).
- 52-week range $1.90–$23.57; today's close sits at 32% of that range, 62.9% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — QTTB jumps 3.1% to $8.34
- Closed at $8.34, +3.09% vs the prior close of $8.09. Day range $7.94–$8.46, opened at $8.12.
- Volume was 854.60K shares, 1.1x its 50-day average of 751.93K.
- Price is -33.9% vs its 50-day average ($12.62) and -5.8% vs its 200-day average ($8.86).
- 52-week range $1.90–$23.57; today's close sits at 30% of that range, 64.6% below the 52-week high.
Oct 8, 2026 — QTTB rises 1.3% to $8.09
- Closed at $8.09, +1.25% vs the prior close of $7.99. Day range $7.62–$8.12, opened at $7.94.
- Volume was 859.60K shares, 1.1x its 50-day average of 749.14K.
- Price is -36.6% vs its 50-day average ($12.76) and -8.4% vs its 200-day average ($8.83).
- 52-week range $1.90–$23.57; today's close sits at 29% of that range, 65.7% below the 52-week high.
Oct 7, 2026 — QTTB dips 1.5% to $7.99, a 3-month low
- Closed at $7.99, -1.48% vs the prior close of $8.11. Day range $7.83–$8.07, opened at $8.00.
- Volume was 569.60K shares, 0.8x its 50-day average of 748.47K.
- Price is -38.0% vs its 50-day average ($12.89) and -9.2% vs its 200-day average ($8.80).
- 52-week range $1.90–$23.57; today's close sits at 28% of that range, 66.1% below the 52-week high.
Oct 6, 2026 — QTTB slides 3.1% to $8.11, a 3-month low
- Closed at $8.11, -3.11% vs the prior close of $8.37. Day range $7.80–$8.36, opened at $8.32.
- Volume was 678.40K shares, 0.9x its 50-day average of 745.45K.
- Price is -37.8% vs its 50-day average ($13.05) and -7.6% vs its 200-day average ($8.78).
- 52-week range $1.90–$23.57; today's close sits at 29% of that range, 65.6% below the 52-week high.
Oct 5, 2026 — QTTB rises 1.7% to $8.37
- Closed at $8.37, +1.70% vs the prior close of $8.23. Day range $7.81–$8.56, opened at $8.09.
- Volume was 954.80K shares, 1.3x its 50-day average of 729.93K.
- Price is -36.5% vs its 50-day average ($13.19) and -4.4% vs its 200-day average ($8.75).
- 52-week range $1.90–$23.57; today's close sits at 30% of that range, 64.5% below the 52-week high.
Oct 2, 2026 — QTTB ends flat (-0.2%) to $8.23, a 3-month low on 3.0x normal volume
- Closed at $8.23, -0.24% vs the prior close of $8.25. Day range $8.17–$9.11, opened at $8.35.
- Volume was 2.10M shares, 3.0x its 50-day average of 695.90K — unusually heavy trading.
- Price is -38.2% vs its 50-day average ($13.33) and -5.7% vs its 200-day average ($8.72).
- 52-week range $1.90–$23.57; today's close sits at 29% of that range, 65.1% below the 52-week high.
- That makes 3 straight losses.
QTTB latest news & SEC filings
Every SEC filing by or about QTTB in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Morrison Jodie Pope sold 3,221 shares at $8.32 (≈$26.80K) on Oct 6, 2026; now holds 340,038
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Violette Shelia M. sold 917 shares at $8.32 (≈$7.63K) on Oct 6, 2026; now holds 126,854
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kalowski Lee sold 1,301 shares at $8.32 (≈$10.82K) on Oct 6, 2026; now holds 137,170
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 9, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Aug 27, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Morrison Jodie Pope sold 9,845 shares at $16.56 (≈$163.03K) on Aug 25, 2026
- Morrison Jodie Pope sold 9,845 shares at $16.56 (≈$163.03K) on Aug 25, 2026
- Morrison Jodie Pope sold 9,845 shares at $16.56 (≈$163.03K) on Aug 25, 2026
- Morrison Jodie Pope sold 9,845 shares at $16.56 (≈$163.03K) on Aug 25, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 27, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kalowski Lee sold 3,972 shares at $16.56 (≈$65.78K) on Aug 25, 2026
- Kalowski Lee sold 3,972 shares at $16.56 (≈$65.78K) on Aug 25, 2026
- Kalowski Lee sold 3,972 shares at $16.56 (≈$65.78K) on Aug 25, 2026
- Kalowski Lee sold 3,972 shares at $16.56 (≈$65.78K) on Aug 25, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 27, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Violette Shelia M. sold 2,798 shares at $16.56 (≈$46.33K) on Aug 25, 2026
- Violette Shelia M. sold 2,798 shares at $16.56 (≈$46.33K) on Aug 25, 2026
- Violette Shelia M. sold 2,798 shares at $16.56 (≈$46.33K) on Aug 25, 2026
- Violette Shelia M. sold 2,798 shares at $16.56 (≈$46.33K) on Aug 25, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$8.95M (prior year -$9.49M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.44 (prior year -$0.78) (loss narrowed vs Jun 30, 2025)
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 31, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 28, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Things to know before you trade QTTB
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Mar 10, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.59% (largest 13.2%). That is a volatile stock.
- Liquidity: about 1.15M shares (≈$8.66M) trade per day on average.
- 52-week position: $7.52 vs a range of $1.90–$23.57 (26% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 13 open-market buys, 12 sales; latest: Lee Kalowski sold 3,972 shares on Aug 25, 2026.
- Latest filings: 8-K Sep 30, 2026; 8-K Sep 14, 2026; 10-Q Aug 5, 2026.
- Share count: 29.77M shares outstanding (Aug 3, 2026), +144.1% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
QTTB market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 7.82 | 7.82 | 7.28 | 7.52 | 677.99K |
| Oct 15, 2026 | 8.01 | 8.29 | 7.72 | 7.77 | 625.30K |
| Oct 14, 2026 | 7.93 | 8.30 | 7.72 | 8.01 | 889.30K |
| Oct 13, 2026 | 8.69 | 8.69 | 7.89 | 8.06 | 719.80K |
| Oct 12, 2026 | 8.64 | 9.15 | 8.44 | 8.74 | 682.30K |
| Oct 9, 2026 | 8.12 | 8.46 | 7.94 | 8.34 | 854.60K |
| Oct 8, 2026 | 7.94 | 8.12 | 7.62 | 8.09 | 859.60K |
| Oct 7, 2026 | 8.00 | 8.07 | 7.83 | 7.99 | 569.60K |
| Oct 6, 2026 | 8.32 | 8.36 | 7.80 | 8.11 | 678.40K |
| Oct 5, 2026 | 8.09 | 8.56 | 7.81 | 8.37 | 954.80K |
| Oct 2, 2026 | 8.35 | 9.11 | 8.17 | 8.23 | 2.10M |
| Oct 1, 2026 | 8.36 | 8.85 | 7.75 | 8.25 | 3.09M |
| Sep 30, 2026 | 10.40 | 10.40 | 7.88 | 8.27 | 5.25M |
| Sep 29, 2026 | 9.32 | 9.66 | 9.16 | 9.53 | 914.80K |
| Sep 28, 2026 | 9.21 | 9.44 | 8.77 | 9.23 | 1.00M |
| Sep 25, 2026 | 9.20 | 9.20 | 8.74 | 8.77 | 514.80K |
| Sep 24, 2026 | 9.51 | 9.55 | 9.05 | 9.22 | 1.07M |
| Sep 23, 2026 | 10.58 | 10.58 | 9.50 | 9.56 | 828.40K |
| Sep 22, 2026 | 10.60 | 10.99 | 10.53 | 10.57 | 387.20K |
| Sep 21, 2026 | 10.57 | 10.75 | 10.30 | 10.47 | 359.00K |
About Q32 Bio
Q32 Bio (QTTB) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in WALTHAM, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1661998.
QTTB board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| David S. Grayzel | Director | Jul 21, 2026 |
| Mark T Iwicki | Director | Jul 21, 2026 |
| Kathleen Laporte | Director | Jul 21, 2026 |
| Sven Ante Lundberg | Director | Jul 21, 2026 |
| Isaac Manke | Director | Jul 21, 2026 |
| Jodie Pope Morrison | CEO | Aug 27, 2026 |
| Advisors Llc Orbimed | Director | Jun 1, 2026 |
| Capital Gp Vii Llc Orbimed | Director | Jun 1, 2026 |
| Genesis Gp Llc Orbimed | Director | Jun 1, 2026 |
| Arthur Tzianabos | Director | Jul 21, 2026 |
| Mary Thistle | Director | Jul 21, 2026 |
| Diyong Xu | Director | Jul 21, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Lee Kalowski | CFO and President | Aug 27, 2026 |
| Jodie Pope Morrison | CEO | Aug 27, 2026 |
| Shelia M. Violette | Chief Scientific Officer | Aug 27, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 25, 2026 | Lee Kalowski | Sale | 3,972 | $16.56 |
| Aug 25, 2026 | Lee Kalowski | Sale | 3,972 | $16.56 |
| Aug 25, 2026 | Lee Kalowski | Sale | 3,972 | $16.56 |
| Aug 25, 2026 | Lee Kalowski | Sale | 3,972 | $16.56 |
| Aug 25, 2026 | Shelia M. Violette | Sale | 2,798 | $16.56 |
| Aug 25, 2026 | Shelia M. Violette | Sale | 2,798 | $16.56 |
| Aug 25, 2026 | Shelia M. Violette | Sale | 2,798 | $16.56 |
| Aug 25, 2026 | Shelia M. Violette | Sale | 2,798 | $16.56 |
| Aug 25, 2026 | Jodie Pope Morrison | Sale | 9,845 | $16.56 |
| Aug 25, 2026 | Jodie Pope Morrison | Sale | 9,845 | $16.56 |
| Aug 25, 2026 | Jodie Pope Morrison | Sale | 9,845 | $16.56 |
| Aug 25, 2026 | Jodie Pope Morrison | Sale | 9,845 | $16.56 |
| May 28, 2026 | Diyong Xu | Buy | 1,250,000 | $8.00 |
| May 28, 2026 | Diyong Xu | Buy | 625,000 | $8.00 |
| May 28, 2026 | Diyong Xu | Buy | 1,250,000 | $8.00 |
QTTB financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $29.82M | 2.42 | $-33.54M |
| Dec 31, 2024 | — | $-47.73M | -6.58 | $-67.72M |
| Dec 31, 2023 | $1.16M | $-53.74M | -153.96 | $-18.68M |
| Dec 31, 2022 | $3.21M | $-5.00M | -0.09 | $-113.66M |
| Dec 31, 2021 | $33.97M | $-95.76M | -1.73 | $-109.75M |
Latest balance sheet: total assets $115.87M, total liabilities $9.96M, cash $106.27M (as of Jun 30, 2026).
QTTB earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $16.49 |
| May 5, 2026 | 8-K Item 2.02 (results) | $5.14 |
| Mar 10, 2026 | 8-K Item 2.02 (results) | $5.99 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $2.21 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $1.95 |
| May 8, 2025 | 8-K Item 2.02 (results) | $1.54 |
| Mar 11, 2025 | 8-K Item 2.02 (results) | $1.90 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $47.46 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Mar 27, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2020 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on QTTB
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.